Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sotrastaurin in active moderate to severe ulcerative colitis
2007-002542-38Phase 2Terminated
- Sponsor
- Novartis
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in autoimmune colitis comparing Sotrastaurin with Placebo (2 arms). Primary endpoint: Clinical remission at 4 weeks. Started Nov 2007; status: terminated.
02
Drugs
sotrastaurin
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on 2007-002542-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002542-38.